Correlation Analysis between Single-Nucleotide Polymorphism and Expression Arrays in Gliomas Identifies Potentially Relevant Target Genes, Cancer Research, vol.69, issue.4, pp.1596-603, 2009. ,
DOI : 10.1158/0008-5472.CAN-08-2496
Gene Regulation by Methylation, Recent Results Cancer Res, vol.171, pp.217-256, 2009. ,
DOI : 10.1007/978-3-540-31206-2_13
Downregulation of RUNX3 and TES by hypermethylation in glioblastoma, Oncogene, vol.32, issue.4, pp.583-93, 2007. ,
DOI : 10.1038/sj.onc.1209805
Epigenomic Profiling Reveals Novel and Frequent Targets of Aberrant DNA Methylation-Mediated Silencing in Malignant Glioma, Cancer Research, vol.66, issue.15, pp.7490-501, 2006. ,
DOI : 10.1158/0008-5472.CAN-05-4552
Genome-Wide Analysis of Epigenetic Silencing Identifies BEX1 and BEX2 as Candidate Tumor Suppressor Genes in Malignant Glioma, Cancer Research, vol.66, issue.13, pp.6665-74, 2006. ,
DOI : 10.1158/0008-5472.CAN-05-4453
DNA methyltransferase-mediated transcriptional silencing in malignant glioma: a combined whole-genome microarray and promoter array analysis, Oncogene, vol.2, issue.29, 2009. ,
DOI : 10.1007/s10350-007-0286-6
CpG island promoter hypermethylation of the pro-apoptotic gene caspase-8 is a common hallmark of relapsed glioblastoma multiforme, Carcinogenesis, vol.28, issue.6, 2007. ,
DOI : 10.1093/carcin/bgm014
Epigenetic Aberrations in Malignant Gliomas: An Open Door Leading to Better Understanding and Treatment, Epigenetics, vol.2, issue.3, pp.147-50, 2007. ,
DOI : 10.4161/epi.2.3.5049
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial, The Lancet Oncology, vol.10, issue.5, pp.459-66, 2009. ,
DOI : 10.1016/S1470-2045(09)70025-7